BRIEF published on 06/01/2026 at 22:10, 2 hours 34 minutes ago European Commission Approves Amgen's IMDYLLTRA® for Lung Cancer Treatment Clinical Trial Results Amgen IMDYLLTRA Approval Small Cell Lung Cancer T-cell Engager Therapy
PRESS RELEASE published on 06/01/2026 at 22:05, 2 hours 39 minutes ago EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER The European Commission has approved Amgen's IMDYLLTRA as a monotherapy for treating extensive-stage small cell lung cancer with a significant survival benefit over chemotherapy European Commission Approval Amgen Small Cell Lung Cancer IMDYLLTRA
BRIEF published on 02/12/2026 at 15:56, 3 months 17 days ago European Commission Approves Amgen's UPLIZNA® for Generalized Myasthenia Gravis European Commission Amgen UPLIZNA GMG CD19-targeted Therapy
PRESS RELEASE published on 02/12/2026 at 15:51, 3 months 17 days ago EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS European Commission approves Amgen's UPLIZNA for Generalized Myasthenia Gravis. New targeted treatment option with twice-yearly dosing for gMG patients European Commission Treatment Amgen UPLIZNA Generalized Myasthenia Gravis
Published on 06/01/2026 at 23:57, 47 minutes ago Metallic Minerals Announces Bought Deal LIFE Private Placement for Gross Proceeds of C$8.0 Million
Published on 06/01/2026 at 23:05, 1 hour 39 minutes ago Faraday Copper Strengthens Team to Support Project Advancement in Arizona
Published on 06/01/2026 at 23:00, 1 hour 44 minutes ago CCL Industries Closing of Sleever International Acquisition
Published on 06/01/2026 at 22:30, 2 hours 14 minutes ago Revolve to Present at the Small Cap Growth Virtual Investor Conference on June 4, 2026
Published on 06/01/2026 at 23:00, 1 hour 44 minutes ago DriveNets Secures $410M Series D to Meet Surging Demand for Ethernet Fabric in Large-Scale AI Deployments
Published on 06/01/2026 at 22:05, 2 hours 39 minutes ago EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Published on 06/01/2026 at 22:05, 2 hours 39 minutes ago Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis
Published on 06/01/2026 at 21:20, 3 hours 24 minutes ago Eurobattery Minerals: Loft Capital exercises conversion rights – Conversion Threshold Date reached and a total of 23,798,419 new shares to be registered
Published on 06/01/2026 at 19:00, 5 hours 44 minutes ago Armen Pogossian Represents Armenia at Forbes Under 30 Summit China, Empowering the Next Generation of Global Entrepreneurs
Published on 06/01/2026 at 18:47, 5 hours 57 minutes ago Disclosure of transactions in own shares from May 25 to May 29, 2026
Published on 06/01/2026 at 18:00, 6 hours 44 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 06/01/2026 at 17:54, 6 hours 50 minutes ago Reporting on share buyback transactions carried out on May 28, 2026
Published on 06/01/2026 at 17:54, 6 hours 50 minutes ago TF1 - Monthly disclosure of the total number of shares and voting rights - May 2026
Published on 06/01/2026 at 17:45, 6 hours 59 minutes ago ENGIE secures €1 billion export financing backed by Euler Hermes
